ABT — Complete Signal History
Every significant change detected in ABT's SEC filings by Tracenotes — language shifts, financial anomalies, and risk signals across all analyzed 10-K and 10-Q filings.
Abbott's net income plummeted 51% from $13.4B to $6.5B despite strong operational performance, while the company announced a major...
Abbott's net income collapsed 51.3% to $6.5B despite 18% operating income growth, indicating significant non-operating headwinds o...
Abbott's net income plummeted 51.3% to $6.5B despite 18% operating income growth, indicating a major non-operating financial impac...
Abbott's net income plummeted 51.3% from $13.4B to $6.5B despite higher operating income, indicating significant non-operating cha...
Abbott's net income collapsed 51.3% to $6.5B despite 18% operating income growth, indicating significant non-operating charges lik...
Abbott's net income plummeted 51.3% from $13.4B to $6.5B despite higher operating income, indicating significant non-operating exp...
Abbott's net income plummeted 51% despite rising operating income, while the company simultaneously announced a major acquisition ...
Abbott announced a major strategic acquisition of Exact Sciences Corporation to enter the cancer diagnostics market, while simulta...
See what changed in ABT's latest filing
500+ S&P 500 companies analyzed. Enter any ticker for instant analysis.
Analyze ABT free →